Merck, OMT announce new antibody discovery collaboration
Open Monoclonal Technology, Inc. (OMT) today announced an antibody discovery collaboration with Merck KGaA. OMT and Merck KGaA have entered into a collaboration whereby OMT will use its OmniRats to generate antibodies against several targets selected..
Original Article: Merck, OMT announce new antibody discovery collaboration
NEXT ARTICLE